Physician profile
William Bruch
NPI 1073975157
$12,333.90
in general payments reported to CMS, 2019-2025
48 companies · $2,203 in 2025
The $2,203 reported for 2025 was more than what 82% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $394 · 2020: $335 · 2021: $920 · 2022: $2,786 · 2023: $3,646 · 2024: $2,050 · 2025: $2,203.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,261 · Travel and Lodging: $603 · Education: $35.06.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,261.05 |
| Travel and Lodging | $602.58 |
| Education | $35.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Procept Biorobotics Corporation | $1,213.38 | 2023-2025 | Aquabeam Robotic System |
| Abbvie INC. | $1,171.01 | 2021-2025 | Botox, Lupron Depot |
| Dendreon Pharmaceuticals LLC | $1,159.10 | 2020-2024 | Provenge |
| Sumitomo Pharma America, INC. | $792.24 | 2023-2025 | Gemtesa, Orgovyx |
| Boston Scientific Corporation | $715.13 | 2019-2024 | Lumenis Pulse 120h, Rhythmia Mapping System |
| Bayer Healthcare Pharmaceuticals INC. | $706.76 | 2021-2025 | |
| Pfizer INC. | $678.17 | 2021-2025 | |
| Blue Earth Diagnostics | $616.79 | 2021-2025 | Posluma |
| Endo Pharmaceuticals INC. | $423.82 | 2021-2024 | Xiaflex, Aveed, Edex |
| Teleflex LLC | $374.88 | 2021-2022 | |
| Astellas Pharma US INC | $371.60 | 2021-2025 | Xtandi |
| Janssen Biotech, INC. | $366.11 | 2022-2025 | Erleada, Akeega |
| Progenics Pharmaceuticals, INC. | $353.90 | 2021-2025 | Pylarify |
| Urogen Pharma, INC. | $346.69 | 2021-2025 | Jelmyto |
| Endo USA, INC. | $262.42 | 2024-2025 | Xiaflex, Aveed |
Show all 48 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $209.67 | 2024-2025 | Adstiladrin |
| Calyxo, INC. | $209.62 | 2025 | Cvac Aspiration System |
| Antares Pharma, INC. | $194.44 | 2022-2025 | Xyosted, Tlando, Nocdurna |
| Astrazeneca Pharmaceuticals LP | $192.62 | 2022-2025 | Lynparza, Imfinzi |
| Accord Healthcare, INC. | $163.67 | 2022-2024 | |
| Palette Life Sciences, INC. | $139.86 | 2022-2023 | |
| Novartis Pharmaceuticals Corporation | $131.70 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $118.32 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Axonics, INC. | $116.15 | 2020-2022 | |
| Karl Storz Endoscopy-America | $111.01 | 2022 | |
| Dornier Medtech America, INC | $109.15 | 2023 | Dornier Medtech |
| Olympus America INC. | $105.15 | 2025 | Itind System |
| Cook Medical LLC | $87.08 | 2021 | |
| Coloplast Corp | $84.21 | 2021-2022 | |
| Amgen INC. | $84.15 | 2021-2022 | |
| Ambu INC. | $83.27 | 2022-2024 | |
| Myovant Sciences INC. | $83.06 | 2021-2022 | |
| Urovant Sciences INC | $75.26 | 2022 | |
| Conmed Corporation | $68.31 | 2019 | |
| Ethicon US, LLC | $59.17 | 2022-2024 | Endopath Xcel, Stratafix, Echelon Flex |
| Inspire Medical Systems, INC. | $47.02 | 2025 | Inspire |
| Travere Therapeutics, INC. | $46.94 | 2021-2022 | |
| Tolmar, INC. | $43.68 | 2024-2025 | Eligard |
| Halozyme INC | $41.44 | 2023 | |
| Clarus Therapeutics INC. | $33.52 | 2021 | |
| Cardinal Health 414 LLC | $30.19 | 2025 | |
| Sun Pharmaceutical Industries INC. | $22.03 | 2024 | |
| Telix Pharmaceuticals | $17.70 | 2022 | |
| Foundation Medicine, INC. | $17.60 | 2021 | |
| Photocure INC | $14.90 | 2022 | |
| Immunitybio, INC. | $14.05 | 2025 | |
| C. R. Bard, INC. & Subsidiaries | $13.90 | 2023 | Bard Urinary Drainage Bag |
| Kowa Pharmaceuticals America, INC. | $13.06 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Bruch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.